WO2023002246 - NOVEL 1,2-DIAMINOBENZIMIDAZOLE DERIVATIVE

National phase entry:
Publication Number WO/2023/002246
Publication Date 26.01.2023
International Application No. PCT/IB2022/000396
International Filing Date 21.07.2022
Title **
[English] NOVEL 1,2-DIAMINOBENZIMIDAZOLE DERIVATIVE
[French] NOUVEAU DÉRIVÉ DE 1,2-DIAMINOBENZIMIDAZOLE
Applicants **
CARNA BIOSCIENCES, INC. 1-5-5, Minatojima-Minamimachi Chuo-ku, Kobe-shi Hyogo, 6500047, JP
Inventors
MATSUMOTO, Hirokazu c/o Carna Biosciences, Inc. 1-5-5, Minatojima-Minamimachi, Chuo-ku, Kobe-shi Hyogo, 6500047, JP
KIYOI, Takao c/o Carna Biosciences, Inc. 1-5-5, Minatojima-Minamimachi, Chuo-ku, Kobe-shi Hyogo, 6500047, JP
TAKAMATSU, Shiori c/o Carna Biosciences, Inc. 1-5-5, Minatojima-Minamimachi, Chuo-ku, Kobe-shi Hyogo, 6500047, JP
SAWA, Masaaki c/o Carna Biosciences, Inc. 1-5-5, Minatojima-Minamimachi, Chuo-ku, Kobe-shi Hyogo, 6500047, JP
Priority Data
2021-120698   21.07.2021   JP
front page image
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
*
International Searching Authority
*
Applicant's Legal Status
*
*
*
*
*
Entry into National Phase under
*
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing430
EPO Filing, Examination6646
Japan Filing503
South Korea Filing543
USA Filing, Examination1460
MasterCard Visa

Total: 9582

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Abstract[English] are defined in the specification.[French] sont tels que définis dans la description.
An unhandled error has occurred. Reload 🗙